Characteristic | Non-sarcopenia | Sarcopenia | p value |
---|---|---|---|
n = 43, 20.2% | n = 170, 79.8% | ||
Age, years | 0.163 | ||
> 65 | 21 | 103 | |
≥ 65 | 22 | 67 | |
Gender | 0.064 | ||
Male | 37 | 123 | |
Female | 6 | 47 | |
Smoking | 0.307 | ||
Yes | 26 | 88 | |
No | 17 | 82 | |
Alcohol | 0.781 | ||
Yes | 21 | 79 | |
No | 22 | 91 | |
BMI, kg/m2 | 0.145 | ||
≥ 24 | 19 | 55 | |
< 24 | 24 | 115 | |
NRI | 0.234 | ||
≥ 100 | 38 | 137 | |
< 100 | 5 | 33 | |
Anemia | 0.325 | ||
Yes | 12 | 61 | |
No | 31 | 109 | |
Albumin | 0.306 | ||
< 40 | 7 | 40 | |
≥ 40 | 36 | 130 | |
SATI (cm2/m2) | 0.009 | ||
≤ 27.8 | 14 | 93 | |
> 27.8 | 29 | 77 | |
VATI (cm2/m2) | 0.633 | ||
≤ 49.0 | 20 | 86 | |
> 49.0 | 23 | 84 | |
TATI (cm2/m2) | 0.133 | ||
≤ 83.0 | 17 | 89 | |
> 83.0 | 26 | 81 | |
Location | 0.063 | ||
Neck/upper | 25 | 72 | |
Middle/lower | 18 | 98 | |
Length (cm) | 0.116 | ||
≤ 4 | 17 | 90 | |
> 4 | 26 | 80 | |
Treatment strategies | 0.678 | ||
RT | 8 | 55 | |
CRT | 36 | 114 | |
TNM stage | 0.871 | ||
I–II | 16 | 61 | |
III–IV | 27 | 109 | |
T stage | 0.961 | ||
T1–2 | 9 | 35 | |
T3–4 | 34 | 135 | |
N stage | 0.683 | ||
N0–1 | 14 | 61 | |
N2–3 | 29 | 109 |